HopeStage
Back to all studies
CompletedNCT04680910

Propofol and brain slow waves in treatment-resistant depression

About this titleRead the official source — NCT04680910
Medication studyAges 60+United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 60 years.

Listed locations
St LouisSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: January 14, 2021
Recruitment status
Completed
Enrollment listed in the registry
16
Sponsor
Washington University School of Medicine
Sponsor type
University
Study type
Drug
Intervention type
Diagnostic test, Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
Over 60 Years
Official registry ID
NCT04680910
Official title
Show the full official title

Precision Targeting of Propofol-induced Electroencephalographic Slow Waves: a Novel Phase I Paradigm for Treatment-resistant Major Depressive Disorder

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

St Louis

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Washington University School of Medicine, a university.

Did this study involve medication?

Yes. The study involved medication, including Propofol.

Who was this study for?

Listed age limits: from 60 years.

Want to explore more studies?

Explore studies